Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Clinical Investigator Award (CIA) (K08)
Project #
1K08HL003194-01A2
Application #
2211310
Study Section
Research Training Review Committee (RTR)
Project Start
1996-02-01
Project End
2000-01-31
Budget Start
1996-02-01
Budget End
1997-01-31
Support Year
1
Fiscal Year
1996
Total Cost
Indirect Cost

  Institution

Name
Harvard University
Department
Public Health & Prev Medicine
Type
Schools of Public Health
DUNS #
082359691
City
Boston
State
MA
Country
United States
Zip Code
02115

  Publications

Maemura, K; Layne, M D; Watanabe, M et al. (2001) Molecular mechanisms of morning onset of myocardial infarction. Ann N Y Acad Sci 947:398-402
Foster, L C; Wiesel, P; Huggins, G S et al. (2000) Role of activating protein-1 and high mobility group-I(Y) protein in the induction of CD44 gene expression by interleukin-1beta in vascular smooth muscle cells. FASEB J 14:368-78
Christou, H; Morita, T; Hsieh, C M et al. (2000) Prevention of hypoxia-induced pulmonary hypertension by enhancement of endogenous heme oxygenase-1 in the rat. Circ Res 86:1224-9
Werner, F; Jain, M K; Feinberg, M W et al. (2000) Transforming growth factor-beta 1 inhibition of macrophage activation is mediated via Smad3. J Biol Chem 275:36653-8
Wiesel, P; Foster, L C; Pellacani, A et al. (2000) Thioredoxin facilitates the induction of heme oxygenase-1 in response to inflammatory mediators. J Biol Chem 275:24840-6
Pellacani, A; Chin, M T; Wiesel, P et al. (1999) Induction of high mobility group-I(Y) protein by endotoxin and interleukin-1beta in vascular smooth muscle cells. Role in activation of inducible nitric oxide synthase. J Biol Chem 274:1525-32
Perrella, M A; Pellacani, A; Wiesel, P et al. (1999) High mobility group-I(Y) protein facilitates nuclear factor-kappaB binding and transactivation of the inducible nitric-oxide synthase promoter/enhancer. J Biol Chem 274:9045-52
Chin, M T; Pellacani, A; Hsieh, C M et al. (1999) Induction of high mobility group I architectural transcription factors in proliferating vascular smooth muscle in vivo and in vitro. J Mol Cell Cardiol 31:2199-205
Hsieh, C M; Yet, S F; Layne, M D et al. (1999) Genomic cloning and promoter analysis of aortic preferentially expressed gene-1. Identification of a vascular smooth muscle-specific promoter mediated by an E box motif. J Biol Chem 274:14344-51
Sibinga, N E; Wang, H; Perrella, M A et al. (1999) Interferon-gamma-mediated inhibition of cyclin A gene transcription is independent of individual cis-acting elements in the cyclin A promoter. J Biol Chem 274:12139-46

Showing the most recent 10 out of 24 publications